compensation: Eligible participants in the study will be compensated
employment type: employee's choice
QR Code Link to This Post
They want to learn more about an investigational drug and its effect on ADHD. The duration of participation in this study will be up to 13 weeks and includes up to 12 study clinic visits and approximately 3 phone calls from study staff
The results of this study will provide more information about the investigational drug and whether it could one day be approved to treat adult ADHD. If you have been diagnosed with ADHD we hope that you will consider learning more about this study.
To pre-qualify for the CAPSTONE study, you must:
All study-related visits, tests, and study drugs will be provided at no cost. In addition, reimbursement for study related travel may be provided.
Ref #: 909-PRI